ADMA Biologics, Inc. is a leading pharmaceutical company based in the United States with a focus on manufacturing specialty plasma-derived biologics for immunodeficient patients and those at risk for infectious diseases. With a high ESG score of 34.8, the company operates in segments such as ADMA BioManufacturing and Plasma Collection Centers. Their FDA-approved products are sold to customers, along with laboratory contracting and contract filling services. Discover more about ADMA Biologics for sustainable healthcare solutions.